摘要
目的探讨磷酸奥司他韦颗粒联合板蓝根颗粒治疗小儿急性病毒性腮腺炎的临床疗效。方法选取我院2014年11月至2017年11月收治的急性病毒性腮腺炎患儿60例,随机分为两组各30例。对照组给予单纯板蓝根颗粒和对症治疗,观察组在此基础上给予磷酸奥司他韦颗粒。比较两组患儿的临床疗效、主要症状消失时间、并发症及不良反应。结果观察组的优良率为93.33%,显著高于对照组的73.33%(P<0.05)。观察组的退烧时间、腮肿消失时间、疼痛消失时间均显著短于对照组(P<0.05);观察组的并发症发生率为3.33%,显著低于对照组的20.00%(P<0.05)。两组患儿的不良反应发生率比较差异无统计学意义(P>0.05)。结论奥司他韦颗粒联合板蓝根颗粒治疗小儿急性病毒性腮腺炎,可显著提高临床疗效,缩短主要症状消失时间,降低并发症发生率,值得临床推广应用。
Objective To explore the clinical curative effect of phosphate oseltamivir granules combined with Banlangen granules in the treatment of children with acute viral parotitis. Methods 60 cases of children with acute viral parotitis admitted to our hospital from November 2014 to November 2017 were selected and randomly divided into two groups, with 30 cases in each group. The control group was given single Banlangen granules and symptomatic treatment, while the observation group was given phosphate oseltamivir granules on this basis. The clinical curative effect, disappearance time of main symptoms, complications and adverse reactions were compared between the two groups. Results The excellent and good rate of the observation group was 93.33%, significantly higher than 73.33% of the control group(P 〈0.05). The disappearance time of fever, mumps and pain of the observation group were significantly shorter than those of the control group(P 〈0.05). The incidence of complications of the observation group was 3.33%, significantly lower than 20.00% of the control group(P 〈0.05). No statistical difference was found in the incidence of adverse reactions between the two groups(P 〉0.05). Conclusions Oseltamivir granules combined with Banlangen granules in the treatment of children with acute viral parotitis can significantly improve the clinical curative effect, shorten the disappearance time of main symptoms, reduce the incidence of complications, which is worthy of clinical promotion and application.
作者
李金鸾
LI Jinluan(Department of Paediatrics, Taishan People’s Hospital,Taishan 529200, Chin)
出处
《临床医学工程》
2018年第5期629-630,共2页
Clinical Medicine & Engineering